Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.

1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management, epilepsy, neurodegenerative disease and depression. More recently 1,2-diarylethylamines have been sold as 'legal highs' in a number of d...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason Wallach, Heather Kang, Tristan Colestock, Hamilton Morris, Zuner A Bortolotto, Graham L Collingridge, David Lodge, Adam L Halberstadt, Simon D Brandt, Adeboye Adejare
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157021&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849435437504921600
author Jason Wallach
Heather Kang
Tristan Colestock
Hamilton Morris
Zuner A Bortolotto
Graham L Collingridge
David Lodge
Adam L Halberstadt
Simon D Brandt
Adeboye Adejare
author_facet Jason Wallach
Heather Kang
Tristan Colestock
Hamilton Morris
Zuner A Bortolotto
Graham L Collingridge
David Lodge
Adam L Halberstadt
Simon D Brandt
Adeboye Adejare
author_sort Jason Wallach
collection DOAJ
description 1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management, epilepsy, neurodegenerative disease and depression. More recently 1,2-diarylethylamines have been sold as 'legal highs' in a number of different forms including powders and tablets. These compounds are sold to circumvent governmental legislation regulating psychoactive drugs. Examples include the opioid MT-45 and the dissociative agents diphenidine (DPH) and 2-methoxy-diphenidine (2-MXP). A number of fatal and non-fatal overdoses have been linked to abuse of these compounds. As with many 'legal highs', little is known about their pharmacology. To obtain a better understanding, the effects of DPH, 2-MXP and its 3- and 4-MeO- isomers, and 2-Cl-diphenidine (2-Cl-DPH) were investigated using binding studies at 46 central nervous system receptors including the N-methyl-D-aspartate receptor (NMDAR), serotonin, dopamine, norepinephrine, histamine, and sigma receptors as well as the reuptake transporters for serotonin, dopamine and norepinephrine. Reuptake inhibition potencies were measured at serotonin, norepinephrine and dopamine transporters. NMDAR antagonism was established in vitro using NMDAR-induced field excitatory postsynaptic potential (fEPSP) experiments. Finally, DPH and 2-MXP were investigated using tests of pre-pulse inhibition of startle (PPI) in rats to determine whether they reduce sensorimotor gating, an effect observed with known dissociative drugs such as phencyclidine (PCP) and ketamine. The results suggest that these 1,2-diarylethylamines are relatively selective NMDAR antagonists with weak off-target inhibitory effects on dopamine and norepinephrine reuptake. DPH and 2-MXP significantly inhibited PPI. DPH showed greater potency than 2-MXP, acting with a median effective dose (ED50) of 9.5 mg/kg, which is less potent than values reported for other commonly abused dissociative drugs such as PCP and ketamine.
format Article
id doaj-art-e97ed5f9486741bebd14a1590aad934e
institution Kabale University
issn 1932-6203
language English
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-e97ed5f9486741bebd14a1590aad934e2025-08-20T03:26:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-01116e015702110.1371/journal.pone.0157021Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.Jason WallachHeather KangTristan ColestockHamilton MorrisZuner A BortolottoGraham L CollingridgeDavid LodgeAdam L HalberstadtSimon D BrandtAdeboye Adejare1,2-Diarylethylamines including lanicemine, lefetamine, and remacemide have clinical relevance in a range of therapeutic areas including pain management, epilepsy, neurodegenerative disease and depression. More recently 1,2-diarylethylamines have been sold as 'legal highs' in a number of different forms including powders and tablets. These compounds are sold to circumvent governmental legislation regulating psychoactive drugs. Examples include the opioid MT-45 and the dissociative agents diphenidine (DPH) and 2-methoxy-diphenidine (2-MXP). A number of fatal and non-fatal overdoses have been linked to abuse of these compounds. As with many 'legal highs', little is known about their pharmacology. To obtain a better understanding, the effects of DPH, 2-MXP and its 3- and 4-MeO- isomers, and 2-Cl-diphenidine (2-Cl-DPH) were investigated using binding studies at 46 central nervous system receptors including the N-methyl-D-aspartate receptor (NMDAR), serotonin, dopamine, norepinephrine, histamine, and sigma receptors as well as the reuptake transporters for serotonin, dopamine and norepinephrine. Reuptake inhibition potencies were measured at serotonin, norepinephrine and dopamine transporters. NMDAR antagonism was established in vitro using NMDAR-induced field excitatory postsynaptic potential (fEPSP) experiments. Finally, DPH and 2-MXP were investigated using tests of pre-pulse inhibition of startle (PPI) in rats to determine whether they reduce sensorimotor gating, an effect observed with known dissociative drugs such as phencyclidine (PCP) and ketamine. The results suggest that these 1,2-diarylethylamines are relatively selective NMDAR antagonists with weak off-target inhibitory effects on dopamine and norepinephrine reuptake. DPH and 2-MXP significantly inhibited PPI. DPH showed greater potency than 2-MXP, acting with a median effective dose (ED50) of 9.5 mg/kg, which is less potent than values reported for other commonly abused dissociative drugs such as PCP and ketamine.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157021&type=printable
spellingShingle Jason Wallach
Heather Kang
Tristan Colestock
Hamilton Morris
Zuner A Bortolotto
Graham L Collingridge
David Lodge
Adam L Halberstadt
Simon D Brandt
Adeboye Adejare
Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
PLoS ONE
title Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
title_full Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
title_fullStr Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
title_full_unstemmed Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
title_short Pharmacological Investigations of the Dissociative 'Legal Highs' Diphenidine, Methoxphenidine and Analogues.
title_sort pharmacological investigations of the dissociative legal highs diphenidine methoxphenidine and analogues
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0157021&type=printable
work_keys_str_mv AT jasonwallach pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT heatherkang pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT tristancolestock pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT hamiltonmorris pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT zunerabortolotto pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT grahamlcollingridge pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT davidlodge pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT adamlhalberstadt pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT simondbrandt pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues
AT adeboyeadejare pharmacologicalinvestigationsofthedissociativelegalhighsdiphenidinemethoxphenidineandanalogues